Literature DB >> 27832845

Predictors of Permanent Pacemaker Implantation After Transcatheter Aortic Valve Replacement With the SAPIEN 3.

Victor Mauri1, Andreas Reimann1, Daniel Stern1, Maximilian Scherner2, Elmar Kuhn2, Volker Rudolph1, Stephan Rosenkranz1, Kaveh Eghbalzadeh2, Kai Friedrichs1, Thorsten Wahlers2, Stephan Baldus1, Navid Madershahian2, Tanja K Rudolph3.   

Abstract

OBJECTIVES: The aim of this study was to identify predictors of permanent pacemaker implantation (PPMI) following transcatheter aortic valve replacement (TAVR) with a balloon-expandable transcatheter valve (Edwards SAPIEN 3).
BACKGROUND: New-onset conduction disturbances requiring PPMI remain a major concern following TAVR. Predictors are not yet well defined.
METHODS: The influence of angiographic implantation depth, device landing zone calcium volume, oversizing, pre- and post-dilation, and baseline conduction disturbances on PPMI rate was analyzed in 229 patients undergoing TAVR with the SAPIEN 3 device.
RESULTS: PPMI was performed in 14.4% of patients. Patients requiring PPMI had higher left ventricular outflow tract (LVOT) calcium volume in the area below the left coronary cusp (LVOTLC) and the area below right coronary cusp (LVOTRC) (LVOTLC median calcium 23.7 mm3 vs. 3.0 mm3; p < 0.001; LVOTRC median calcium 6.6 mm3 vs. 0.3 mm3; p = 0.014), a higher prevalence of pre-existing right bundle branch block (15% vs. 2%, p = 0.004), and lower implantation depth (ventricular portion of the stent frame 29 ± 12% vs. 21 ± 5%; p < 0.001). On multivariate regression analysis, LVOTLC calcium volume >13.7 mm3, LVOTRC calcium volume >4.8 mm3, pre-existing right bundle branch block, and implantation depth >25.5% emerged as independent predictors of PPMI. Upon modification of the implantation technique, aiming at a high final valve position, implantation depth decreased from 24% ventricular portion to 21% (p = 0.012), accompanied by a decrease in PPMI rate (19.2% vs. 9.2%; p = 0.038).
CONCLUSIONS: LVOTLC and LVOTRC calcium load, baseline right bundle branch block, and implantation depth were identified as independent predictors of the need for PPMI post-TAVR. Patient groups with different PPMI risk could be stratified using these 4 predictors. A slightly higher valve implantation site may prevent excessive PPMI rates.
Copyright © 2016 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  SAPIEN 3; calcium distribution; permanent pacemaker implantation; transcatheter aortic valve replacement

Mesh:

Year:  2016        PMID: 27832845     DOI: 10.1016/j.jcin.2016.08.034

Source DB:  PubMed          Journal:  JACC Cardiovasc Interv        ISSN: 1936-8798            Impact factor:   11.195


  35 in total

Review 1.  Permanent pacemaker insertion in patients with conduction abnormalities post transcatheter aortic valve replacement: a review and proposed guidelines.

Authors:  Tamunoinemi Bob-Manuel; Amit Nanda; Samuel Latham; Issa Pour-Ghaz; William Paul Skelton; Rami N Khouzam
Journal:  Ann Transl Med       Date:  2018-01

2.  Predictors for permanent pacemaker implantation in patients undergoing transfemoral aortic valve implantation with the Edwards Sapien 3 valve.

Authors:  Birgid Gonska; Julia Seeger; Mirjam Keßler; Alexander von Keil; Wolfgang Rottbauer; Jochen Wöhrle
Journal:  Clin Res Cardiol       Date:  2017-03-10       Impact factor: 5.460

3.  Effect of new and persistent left bundle branch block after transcatheter aortic valve replacement on long-term need for pacemaker implantation.

Authors:  Mohanad Hamandi; Deborah Tabachnick; Allison T Lanfear; Ronald Baxter; Kathryn Shin; Brittany Zingler; Michael J Mack; J Michael DiMaio; Steven Kindsvater
Journal:  Proc (Bayl Univ Med Cent)       Date:  2020-01-30

4.  Predictors of paravalvular regurgitation and permanent pacemaker implantation after TAVR with a next-generation self-expanding device.

Authors:  Victor Mauri; Florian Deuschl; Thomas Frohn; Niklas Schofer; Matthias Linder; Elmar Kuhn; Andreas Schaefer; Volker Rudolph; Navid Madershahian; Lenard Conradi; Tanja K Rudolph; Ulrich Schäfer
Journal:  Clin Res Cardiol       Date:  2018-04-17       Impact factor: 5.460

5.  Predictors of right ventricular pacing and pacemaker dependence in transcatheter aortic valve replacement patients.

Authors:  Esseim Sharma; Antony F Chu
Journal:  J Interv Card Electrophysiol       Date:  2017-12-19       Impact factor: 1.900

Review 6.  Should All Low-risk Patients Now Be Considered for TAVR? Operative Risk, Clinical, and Anatomic Considerations.

Authors:  Saima Siddique; Hemal Gada; Mubashir A Mumtaz; Amit N Vora
Journal:  Curr Cardiol Rep       Date:  2019-11-28       Impact factor: 2.931

7.  Characteristics of and current practice patterns of pacing for high-degree atrioventricular block after transcatheter aortic valve implantation in comparison to surgical aortic valve replacement.

Authors:  Naoki Misumida; Mariah Pagath; Gbolahan O Ogunbayo; Ryan E Wilson; Sun Moon Kim; Ahmed Abdel-Latif; Claude S Elayi
Journal:  Catheter Cardiovasc Interv       Date:  2018-10-09       Impact factor: 2.692

8.  Impact of postprocedural permanent pacemaker implantation on clinical outcomes after transcatheter aortic valve replacement: a systematic review and meta-analysis.

Authors:  Ziwei Xi; Tong Liu; Jing Liang; Yu-Jie Zhou; Wei Liu
Journal:  J Thorac Dis       Date:  2019-12       Impact factor: 2.895

9.  Association of individual aortic leaflet calcification on paravalvular regurgitation and conduction abnormalities with self-expanding trans-catheter aortic valve insertion.

Authors:  Ciara Mahon; Allan Davies; Alessia Gambaro; Francesca Musella; Ana Luisa Costa; Vasileios Panoulas; Edward Nicol; Alison Duncan; Simon Davies; Saeed Mirsadraee
Journal:  Quant Imaging Med Surg       Date:  2021-05

10.  Overcoming the transcatheter aortic valve replacement Achilles heel: conduction abnormalities-a systematic review.

Authors:  Alberto Alperi; Guillem Muntané-Carol; Afonso B Freitas-Ferraz; Lucia Junquera; David Del Val; Laurent Faroux; François Philippon; Josep Rodés-Cabau
Journal:  Ann Cardiothorac Surg       Date:  2020-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.